Targeting gut microbiota and metabolism as the major probiotic mechanism-An evidence-based review

被引:149
作者
Ma, Teng [1 ,2 ,3 ]
Shen, Xin [1 ,2 ,3 ]
Shi, Xuan [1 ,2 ,3 ]
Sakandar, Hafiz Arbab [1 ,2 ,3 ]
Quan, Keyu [1 ,2 ,3 ]
Li, Yalin [1 ,2 ,3 ]
Jin, Hao [1 ,2 ,3 ]
Kwok, Lai-Yu [1 ,2 ,3 ]
Zhang, Heping [1 ,2 ,3 ]
Sun, Zhihong [1 ,2 ,3 ]
机构
[1] Inner Mongolia Agr Univ, Key Lab Dairy Biotechnol & Engn, Minist Educ, Hohhot 010018, Peoples R China
[2] Inner Mongolia Agr Univ, Key Lab Dairy Prod Proc, Minist Agr & Rural Affairs, Hohhot 010018, Peoples R China
[3] Inner Mongolia Agr Univ, Inner Mongolia Key Lab Dairy Biotechnol & Engn, Hohhot 010018, Peoples R China
基金
中国国家自然科学基金;
关键词
Probiotics; Gut microbiota; Metabolites; Host health; Evidence-based research; INTESTINAL BARRIER FUNCTION; CHAIN AMINO-ACIDS; DOUBLE-BLIND; LACTOBACILLUS-RHAMNOSUS; BRANCHED-CHAIN; TRYPTOPHAN-METABOLISM; GLUCOSE-HOMEOSTASIS; CELL-PROLIFERATION; KYNURENINE PATHWAY; RANDOMIZED-TRIAL;
D O I
10.1016/j.tifs.2023.06.013
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Background: The human gut hosts complex microbial communities, which are linked to health and disease. The gut microbiota is continuously reshaped by multiple environmental factors, especially diet. Gut dysbiosis may promote various metabolic, neurological, intestinal, and cardiovascular diseases, and even tumor development. Probiotics have shown promising prophylactic, mitigating, or even curative effects when use as nutrient supplements or adjunctive therapy. These beneficial and/or symptom alleviation effects are often accompanied by gut microbiome and metabolome changes.Scope and approach: Differing from other published review articles, here we summarized the latest knowledge of evidence-based health-promoting effects of probiotics by scouring literature of recent animal and human probiotic intervention studies.Key findings and conclusions: To elucidate the beneficial mechanisms of probiotics in enhancing intestinal homeostasis, intestinal barrier function, host immunity, and through modulating the gut microbiome and its metabolites. Meanwhile, we also discussed challenges in data analysis in clinical research of probiotics and data comparison between laboratories, and provides an outlook for future perspectives in the applications of probiotics. Key findings and conclusions: The beneficial mechanisms of probiotics are achieved through enhancing intestinal homeostasis, intestinal barrier function, host immunity, and gut microbiome and metabolome modulation. Current challenges in data analysis and comparison in clinical research of probiotics are discussed. Finally, an outlook for future perspectives in the applications of probiotics is provided.
引用
收藏
页码:178 / 198
页数:21
相关论文
共 299 条
[1]   Gut Microbiota and Obesity: A Role for Probiotics [J].
Abenavoli, Ludovico ;
Scarpellini, Emidio ;
Colica, Carmela ;
Boccuto, Luigi ;
Salehi, Bahare ;
Sharifi-Rad, Javad ;
Aiello, Vincenzo ;
Romano, Barbara ;
De Lorenzo, Antonino ;
Izzo, Angelo A. ;
Capasso, Raffaele .
NUTRIENTS, 2019, 11 (11)
[2]   Understanding the role of the gut microbiome in gastrointestinal cancer: A review [J].
Agagunduz, Duygu ;
Cocozza, Ermelinda ;
Cemali, Oezge ;
Bayazit, Ayse Derya ;
Nani, Maria Francesca ;
Cerqua, Ida ;
Morgillo, Floriana ;
Saygili, Suna Karadeniz ;
Berni Canani, Roberto ;
Amero, Paola ;
Capasso, Raffaele .
FRONTIERS IN PHARMACOLOGY, 2023, 14
[3]   Recent developments in the probiotics as live biotherapeutic products (LBPs) as modulators of gut brain axis related neurological conditions [J].
Agagunduz, Duygu ;
Gencer Bingol, Feray ;
Celik, Elif ;
Cemali, Ozge ;
Ozenir, Ciler ;
Ozogul, Fatih ;
Capasso, Raffaele .
JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
[4]   Microbiota alteration and modulation in Alzheimer's disease by gerobiotics: The gut-health axis for a good mind [J].
Agagunduz, Duygu ;
Kocaadam-Bozkurt, Betul ;
Bozkurt, Osman ;
Sharma, Heena ;
Esposito, Renata ;
Ozogul, Fatih ;
Capasso, Raffaele .
BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
[5]   Gut microbiota-derived metabolites as central regulators in metabolic disorders [J].
Agus, Allison ;
Clement, Karine ;
Sokol, Harry .
GUT, 2021, 70 (06) :1174-1182
[6]   Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease [J].
Agus, Allison ;
Planchais, Julien ;
Sokol, Harry .
CELL HOST & MICROBE, 2018, 23 (06) :716-724
[7]   High-Molecular-Weight Dextran-Type Exopolysaccharide Produced by the Novel Apilactobacillus waqarii Improves Metabolic Syndrome: In Vitro and In Vivo Analyses [J].
Ahmad, Waqar ;
Boyajian, Jacqueline L. ;
Abosalha, Ahmed ;
Nasir, Anam ;
Ashfaq, Iram ;
Islam, Paromita ;
Schaly, Sabrina ;
Thareja, Rahul ;
Hayat, Azam ;
Rehman, Mujaddad Ur ;
Anwar, Munir Ahmad ;
Prakash, Satya .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
[8]   A human-origin probiotic cocktail ameliorates aging-related leaky gut and inflammation via modulating the microbiota/taurine/tight junction axis [J].
Ahmadi, Shokouh ;
Wang, Shaohua ;
Nagpal, Ravinder ;
Wang, Bo ;
Jain, Shalini ;
Razazan, Atefeh ;
Mishra, Sidharth P. ;
Zhu, Xuewei ;
Wang, Zhan ;
Kavanagh, Kylie ;
Yadav, Hariom .
JCI INSIGHT, 2020, 5 (09)
[9]   The triglyceride-lowering effect of supplementation with dual probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032: Reduction of fasting plasma lysophosphatidylcholines in nondiabetic and hypertriglyceridemic subjects [J].
Ahn, H. Y. ;
Kim, M. ;
Ahn, Y-T. ;
Sim, J-H. ;
Choi, I-D. ;
Lee, S-H. ;
Lee, J. H. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2015, 25 (08) :724-733
[10]   Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH [J].
Al-Dury, Samer ;
Marschall, Hanns-Ulrich .
FRONTIERS IN PHARMACOLOGY, 2018, 9